Thursday, December 12

Healthcare

Merck, Daiichi post mid-stage data for novel lung cancer drug

09/10/20241 Min Read

cancer Daiichi data drug lung Merck midstage post

Previous ArticleQuantum Biopharma regains Nasdaq compliance

Next Article Piper Sandler ups Intra-Cellular to obese, cites Caplyta potential